Effect of COVID-19 on Blood Pressure Profile and Oxygen Pulse during and after the Cardiopulmonary Exercise Test in Healthy Adults.

Publication date: Jul 04, 2023

Several reports have shown the impact of COVID-19 history on exercise capacity. This study compared the blood pressure (BP) response and oxygen pulse (O pulse) characteristics in normotensive patients with and without a history of COVID-19 during the cardiopulmonary exercise test (CPET) and post-exercise recovery. This cross-sectional study involved 130 healthy Caucasian adult volunteers (71 participants with a history of COVID-19). All patients underwent the CPET with blood pressure measurements during exercise and post-exercise recovery. The post-COVID group had significantly higher systolic, diastolic, and mean blood pressure after 9 min of recovery and achieved a significantly lower max O pulse (2. 02 mL/beat on average) than the controls. It should be noted that the COVID group tended to have higher blood pressure values in all steps, with no differences in heart rate, pulse pressure, and saturation at any step. The COVID-19 outbreak was associated with a higher blood pressure response, significantly, in post-exercise recovery, a lower maximum O pulse, and a lower maximum load achievement. Future studies are needed to determine if these abnormalities during the CPET and the blood pressure variation have prognostic value.

Open Access PDF

Concepts Keywords
Adults blood pressure
Bp cardiopulmonary exercise test
Cardiopulmonary COVID-19
Caucasian oxygen pulse
Volunteers post-exercise recovery


Type Source Name
disease MESH COVID-19
disease IDO blood
drug DRUGBANK Oxygen
disease IDO history
disease MESH abnormalities
drug DRUGBANK Coenzyme M
drug DRUGBANK Uridine monophosphate
pathway REACTOME Metabolism
disease MESH syndrome
disease MESH infection
drug DRUGBANK Gold
disease VO effective
disease MESH hypertension
disease MESH comorbidity
disease VO organ
disease MESH stroke
disease VO volume
disease VO population
disease VO USA
drug DRUGBANK 8-cyclopentyl-1 3-dipropylxanthine
disease VO device
disease VO protocol
disease VO frequency
disease MESH complications
disease VO vaccination
drug DRUGBANK Tacrine
disease VO ReCOV
disease VO time
disease MESH inflammation
disease MESH ischemia
disease IDO acute infection

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *